应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRUS Merus B.V.
盘前交易 07-24 09:08:42 EDT
64.15
+0.89
+1.41%
盘前
63.97
-0.18
-0.28%
08:43 EDT
最高
64.88
最低
62.78
成交量
49.12万
今开
63.95
昨收
63.26
日振幅
3.32%
总市值
47.78亿
流通市值
38.83亿
总股本
7,448万
成交额
3,151万
换手率
0.81%
流通股本
6,054万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Merus N.V.盘中异动 股价大涨5.02%
市场透视 · 07-17
Merus N.V.盘中异动 股价大涨5.02%
Merus N.V.盘中异动 下午盘股价大涨5.24%报55.07美元
市场透视 · 07-09
Merus N.V.盘中异动 下午盘股价大涨5.24%报55.07美元
Merus N.V.盘中异动 早盘大幅下挫7.16%
市场透视 · 06-04
Merus N.V.盘中异动 早盘大幅下挫7.16%
生物科技公司Merus NV增发新股寻求融资2.5亿美元
DoNews · 06-03
生物科技公司Merus NV增发新股寻求融资2.5亿美元
Merus N.V.盘中异动 下午盘急速下挫5.06%报52.35美元
市场透视 · 05-27
Merus N.V.盘中异动 下午盘急速下挫5.06%报52.35美元
Merus N.V.股价拉升19.46% 市值涨6.69亿美元
市场透视 · 05-23
Merus N.V.股价拉升19.46% 市值涨6.69亿美元
Merus N.V.盘中异动 股价大涨5.20%报43.51美元
市场透视 · 05-20
Merus N.V.盘中异动 股价大涨5.20%报43.51美元
Merus N.V.盘中异动 股价大涨5.09%
市场透视 · 05-12
Merus N.V.盘中异动 股价大涨5.09%
Merus N.V.盘中异动 早盘股价大涨5.00%
市场透视 · 05-08
Merus N.V.盘中异动 早盘股价大涨5.00%
Merus N.V.盘中异动 早盘快速拉升5.22%
市场透视 · 05-07
Merus N.V.盘中异动 早盘快速拉升5.22%
Merus N.V.盘中异动 早盘股价大跌5.19%报41.11美元
市场透视 · 05-06
Merus N.V.盘中异动 早盘股价大跌5.19%报41.11美元
Merus N.V.盘中异动 股价大涨5.04%
市场透视 · 04-24
Merus N.V.盘中异动 股价大涨5.04%
Merus N.V.盘中异动 急速上涨5.08%报40.58美元
市场透视 · 04-11
Merus N.V.盘中异动 急速上涨5.08%报40.58美元
B of A Securities:维持Merus(MRUS.US)评级,由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。
金融界 · 03-10
B of A Securities:维持Merus(MRUS.US)评级,由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。
Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80),销售额$36.133未达$38.544M估值
财报速递 · 02-27
Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80),销售额$36.133未达$38.544M估值
Merus N.V.盘中异动 早盘快速上涨5.02%
市场透视 · 02-26
Merus N.V.盘中异动 早盘快速上涨5.02%
Merus N.V.盘中异动 股价大涨5.04%
市场透视 · 02-19
Merus N.V.盘中异动 股价大涨5.04%
Merus N.V.盘中异动 股价大涨5.02%报42.22美元
市场透视 · 02-18
Merus N.V.盘中异动 股价大涨5.02%报42.22美元
Merus(MRUS.US)获Piper Sandler首次覆盖,给予增持评级, 目标价84.00美元。
金融界 · 02-13
Merus(MRUS.US)获Piper Sandler首次覆盖,给予增持评级, 目标价84.00美元。
Merus N.V.盘中异动 股价大跌5.34%报41.51美元
市场透视 · 01-13
Merus N.V.盘中异动 股价大跌5.34%报41.51美元
加载更多
公司概况
公司名称:
Merus B.V.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Merus N.V.是在荷兰法律下成立于2003年6月16日。该公司是一个临床阶段的免疫肿瘤学公司开发创新的双特异性抗体治疗。其全长人双特异性抗体的候选人的管道,他们将其称为biclonics,从他们技术平台产生。
发行价格:
--
{"stockData":{"symbol":"MRUS","market":"US","secType":"STK","nameCN":"Merus B.V.","latestPrice":64.15,"timestamp":1753300800000,"preClose":63.26,"halted":0,"volume":491196,"hourTrading":{"tag":"盘前","latestPrice":63.97,"preClose":64.15,"latestTime":"08:43 EDT","volume":1,"amount":63.97,"timestamp":1753360988368},"delay":0,"floatShares":60536500,"shares":74476734,"eps":-4.142318,"marketStatus":"盘前交易","change":0.89,"latestTime":"07-24 09:08:42 EDT","open":63.95,"high":64.88,"low":62.78,"amount":31512198.00792,"amplitude":0.033196,"askPrice":64.65,"askSize":193,"bidPrice":50.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.142318,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753363800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1463630400000,"exchange":"NASDAQ","adjPreClose":64.15,"preHourTrading":{"tag":"盘前","latestPrice":63.97,"preClose":64.15,"latestTime":"08:43 EDT","volume":1,"amount":63.97,"timestamp":1753360988368},"postHourTrading":{"tag":"盘后","latestPrice":64.15,"preClose":64.15,"latestTime":"18:12 EDT","volume":6213,"amount":398412.344,"timestamp":1753308731414},"volumeRatio":0.5085313935441031,"impliedVol":0.5011,"impliedVolPercentile":0.2851},"requestUrl":"/m/hq/s/MRUS","defaultTab":"news","newsList":[{"id":"2552482374","title":"Merus N.V.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482374?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:43","pubTimestamp":1752759839,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时43分,Merus N.V.股票出现波动,股价急速拉升5.02%。截至发稿,该股报59.34美元/股,成交量9.3752万股,换手率0.13%,振幅4.19%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.29%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214400a45144e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214400a45144e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","MRUS"],"gpt_icon":0},{"id":"2550520336","title":"Merus N.V.盘中异动 下午盘股价大涨5.24%报55.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520336?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:15","pubTimestamp":1752081338,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时15分,Merus N.V.股票出现异动,股价急速上涨5.24%。截至发稿,该股报55.07美元/股,成交量63.3263万股,换手率0.85%,振幅4.56%。Merus N.V.股票所在的生物技术行业中,整体涨幅为1.06%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710011539953c63a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710011539953c63a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","MRUS","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2540061335","title":"Merus N.V.盘中异动 早盘大幅下挫7.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540061335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540061335?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:31","pubTimestamp":1749043883,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时31分,Merus N.V.股票出现波动,股价大幅下挫7.16%。截至发稿,该股报57.95美元/股,成交量47.4749万股,换手率0.69%,振幅0.85%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.36%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213123a499fb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213123a499fb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","MRUS"],"gpt_icon":0},{"id":"2540170042","title":"生物科技公司Merus NV增发新股寻求融资2.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540170042","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540170042?lang=zh_cn&edition=full","pubTime":"2025-06-04 05:54","pubTimestamp":1748987642,"startTime":"0","endTime":"0","summary":"近日,生物科技公司Merus NV计划通过增发新股筹集2.5亿美元资金。此举旨在加强公司财务状况并推动新药研发。具体融资细节尚未公开,但已引起市场广泛关注。此消息由知情人士透露,显示出资本市场对生物技术领域的持续兴趣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604055617950d74ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604055617950d74ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","MRUS","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2538968114","title":"Merus N.V.盘中异动 下午盘急速下挫5.06%报52.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538968114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538968114?lang=zh_cn&edition=full","pubTime":"2025-05-28 01:16","pubTimestamp":1748366191,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日01时16分,Merus N.V.股票出现波动,股价急速下跌5.06%。截至发稿,该股报52.35美元/股,成交量133.823万股,换手率1.93%,振幅9.10%。Merus N.V.股票所在的生物技术行业中,整体涨幅为1.13%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。该公司正在开发全长人类多特异性抗体治疗药物,称为 Biclonics。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528011631a6ef3533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528011631a6ef3533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","MRUS","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2537174134","title":"Merus N.V.股价拉升19.46% 市值涨6.69亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537174134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537174134?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:31","pubTimestamp":1748007071,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时31分,Merus N.V.股票出现异动,股价急速拉升19.46%。截至发稿,该股报49.70美元/股,成交量16.7459万股,换手率0.24%,振幅1.81%。Merus N.V.股票所在的生物技术行业中,整体跌幅为0.84%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213111a489c4bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213111a489c4bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2536564111","title":"Merus N.V.盘中异动 股价大涨5.20%报43.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536564111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536564111?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:35","pubTimestamp":1747755319,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时35分,Merus N.V.股票出现波动,股价大幅拉升5.20%。截至发稿,该股报43.51美元/股,成交量82.5029万股,换手率1.19%,振幅7.26%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.43%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520233519aa2c943c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520233519aa2c943c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXS","LU0889565916.HKD","BK4082","BK4139","MRUS","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2534750042","title":"Merus N.V.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534750042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534750042?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:38","pubTimestamp":1747057097,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时38分,Merus N.V.股票出现异动,股价急速拉升5.09%。截至发稿,该股报42.98美元/股,成交量1.4804万股,换手率0.02%,振幅2.20%。Merus N.V.股票所在的生物技术行业中,整体涨幅为2.81%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505122138179757459b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505122138179757459b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","LU0320765992.SGD","LU0109394709.USD","MRUS"],"gpt_icon":0},{"id":"2533588491","title":"Merus N.V.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533588491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533588491?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:23","pubTimestamp":1746717804,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时23分,Merus N.V.股票出现异动,股价快速拉升5.00%。截至发稿,该股报41.40美元/股,成交量37.3911万股,换手率0.54%,振幅4.03%。机构评级方面,在所有18家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。Merus N.V.股票所在的生物技术行业中,整体跌幅为2.84%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232324aa2c87b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232324aa2c87b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","MRUS","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533838958","title":"Merus N.V.盘中异动 早盘快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533838958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533838958?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:30","pubTimestamp":1746624652,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时30分,Merus N.V.股票出现波动,股价大幅上涨5.22%。截至发稿,该股报41.51美元/股,成交量4048股,换手率0.01%,振幅0.00%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.00%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721305294ef50ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721305294ef50ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","MRUS","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2533656417","title":"Merus N.V.盘中异动 早盘股价大跌5.19%报41.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533656417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533656417?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:11","pubTimestamp":1746544262,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时11分,Merus N.V.股票出现波动,股价大幅下跌5.19%。截至发稿,该股报41.11美元/股,成交量9.7084万股,换手率0.14%,振幅4.14%。Merus N.V.股票所在的生物技术行业中,整体跌幅为4.45%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。该公司正在开发全长人类多特异性抗体治疗药物,称为 Biclonics。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062311029750d467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062311029750d467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0889565916.HKD","MRUS","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2530964216","title":"Merus N.V.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530964216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530964216?lang=zh_cn&edition=full","pubTime":"2025-04-25 03:06","pubTimestamp":1745521609,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日03时06分,Merus N.V.股票出现波动,股价快速拉升5.04%。截至发稿,该股报43.94美元/股,成交量79.087万股,换手率1.14%,振幅5.50%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.42%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。该公司正在开发全长人类多特异性抗体治疗药物,称为 Biclonics。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042503065194e165ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042503065194e165ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4139","MRUS","LU0320765992.SGD"],"gpt_icon":0},{"id":"2526137666","title":"Merus N.V.盘中异动 急速上涨5.08%报40.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526137666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526137666?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:57","pubTimestamp":1744390630,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时57分,Merus N.V.股票出现波动,股价大幅上涨5.08%。截至发稿,该股报40.58美元/股,成交量32.1752万股,换手率0.47%,振幅6.08%。Merus N.V.股票所在的生物技术行业中,整体涨幅为1.74%。Merus N.V.公司简介:Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门,包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041200571094d31657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041200571094d31657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4139","MRUS","LU0889565916.HKD"],"gpt_icon":0},{"id":"2518720878","title":"B of A Securities:维持Merus(MRUS.US)评级,由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720878","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720878?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Merus(MRUS.US)评级,由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRUS"],"gpt_icon":0},{"id":"1110650193","title":"Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80),销售额$36.133未达$38.544M估值","url":"https://stock-news.laohu8.com/highlight/detail?id=1110650193","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110650193?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692783,"startTime":"0","endTime":"0","summary":"Merus 报告季度每股亏损$,优于分析师一致预期的$,上升了11.84%。该公司报告的季度销售额为$36.133,未达到分析师一致预期的$38.544百万。以上内容来自Benzinga Earnings专栏,原文如下:Merus reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.84 percent. The company reported quarterly sales of $36.133 which missed the analyst consensus estimate of $38.544 million by 100.00 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80),销售额$36.133未达$38.544M估值","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRUS"],"gpt_icon":0},{"id":"2514685102","title":"Merus N.V.盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685102?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:09","pubTimestamp":1740582563,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时09分,Merus N.V.股票出现波动,股价急速上涨5.02%。截至发稿,该股报46.63美元/股,成交量10.4188万股,换手率0.15%,振幅5.11%。Merus N.V.股票所在的生物技术行业中,整体跌幅为0.06%。Merus N.V.公司简介:Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230923a254ffa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230923a254ffa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2512360494","title":"Merus N.V.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512360494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512360494?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:59","pubTimestamp":1739995187,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时59分,Merus N.V.股票出现异动,股价快速拉升5.04%。截至发稿,该股报44.40美元/股,成交量40.5406万股,换手率0.59%,振幅5.73%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.61%。Merus N.V.公司简介:Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220035947988b64b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220035947988b64b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","MRUS","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2512164147","title":"Merus N.V.盘中异动 股价大涨5.02%报42.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512164147?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:51","pubTimestamp":1739893915,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时51分,Merus N.V.股票出现波动,股价急速上涨5.02%。截至发稿,该股报42.22美元/股,成交量19.3414万股,换手率0.28%,振幅4.15%。Merus N.V.股票所在的生物技术行业中,整体涨幅为0.83%。Merus N.V.公司简介:Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182351559627a645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182351559627a645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","MRUS"],"gpt_icon":0},{"id":"2511021510","title":"Merus(MRUS.US)获Piper Sandler首次覆盖,给予增持评级, 目标价84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511021510","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511021510?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:53","pubTimestamp":1739443989,"startTime":"0","endTime":"0","summary":"Merus(MRUS.US)获Piper Sandler首次覆盖,给予增持评级, 目标价84.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13185348145391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRUS"],"gpt_icon":0},{"id":"2503837585","title":"Merus N.V.盘中异动 股价大跌5.34%报41.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503837585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503837585?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778712,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分,Merus N.V.股票出现波动,股价快速下挫5.34%。截至发稿,该股报41.51美元/股,成交量1.1042万股,换手率0.02%,振幅0.16%。Merus N.V.股票所在的生物技术行业中,整体跌幅为1.01%。Merus N.V.公司简介:Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153a2203ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153a2203ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","LU0109394709.USD","MRUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merus.nl","stockEarnings":[{"period":"1week","weight":0.1353},{"period":"1month","weight":0.2163},{"period":"3month","weight":0.4461},{"period":"6month","weight":0.5533},{"period":"1year","weight":0.1554},{"period":"ytd","weight":0.5256}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.1601},{"period":"6month","weight":0.0432},{"period":"1year","weight":0.1452},{"period":"ytd","weight":0.0821}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Merus N.V.是在荷兰法律下成立于2003年6月16日。该公司是一个临床阶段的免疫肿瘤学公司开发创新的双特异性抗体治疗。其全长人双特异性抗体的候选人的管道,他们将其称为biclonics,从他们技术平台产生。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.093783},{"month":2,"riseRate":0.555556,"avgChangeRate":0.063295},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.034321},{"month":4,"riseRate":0.555556,"avgChangeRate":0.005312},{"month":5,"riseRate":0.555556,"avgChangeRate":0.022377},{"month":6,"riseRate":0.6,"avgChangeRate":0.06743},{"month":7,"riseRate":0.5,"avgChangeRate":0.025678},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.009107},{"month":9,"riseRate":0.444444,"avgChangeRate":0.106522},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.037474},{"month":11,"riseRate":0.444444,"avgChangeRate":0.006117},{"month":12,"riseRate":0.777778,"avgChangeRate":0.086715}],"exchange":"NASDAQ","name":"Merus B.V.","nameEN":"Merus NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Merus B.V.,MRUS,Merus B.V.股票,Merus B.V.股票老虎,Merus B.V.股票老虎国际,Merus B.V.行情,Merus B.V.股票行情,Merus B.V.股价,Merus B.V.股市,Merus B.V.股票价格,Merus B.V.股票交易,Merus B.V.股票购买,Merus B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}